Methods for continuous manufacture of liposomal drug products
US11571386B2 · kind B2 · utility
5Cited by
276References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 29, 2019 |
| Grant date | Feb 7, 2023 |
| Priority date | — |
| Expiry date | Feb 1, 2040 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01F2101/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for making liposomal API formulations via continuous in-line diafiltration processes. Also provided herein are liposomal API formulations manufactured by the disclosed methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.